Form D · Investing
Bioverge Funds, Thryve II, LLC
Boise, ID · CIK 0001806768
Offering snapshot reported Mar 16, 2020 · SEC filing
- Reported sold
- $140K Offering amount: $145K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Mar 13, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 16, 2020 | Initial | $139,700 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-362939
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bioverge Funds Management, LLC | None |
Source: Form D, filed Mar 16, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Bioverge Funds Management, Llc Littman | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
575 E Parkcenter Blvd #150
Boise, ID, 83706
Boise, ID, 83706